-
CStone Announces Presentation of Multispecific Antibody Candidate Therapy CS2006/NM21-1480 Study Data at the 2022 American Association for Cancer Research (AACR) Annual Meeting
Time of Update: 2022-05-22
<> /* Style Definitions */ span. prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a. prnews_a { color:blue; } li. prnews_li { font-size:8pt; font-family:"Arial"; color:black; } p. prne
-
Reducing strokes caused by tiny air bubbles entering bloodstream during heart surgery
Time of Update: 2022-05-21
Researchers from the University of Bristol are studying how to reduce strokes and other brain problems after heart surgery, which can be caused by tiny air bubbles left in the blood when the heart is opened .
-
Junshi Bio's Toripalimab for the Treatment of Small Cell Lung Cancer Receives Orphan Drug Designation by the U.S. FDA
Time of Update: 2022-05-21
The orphan drug designation issued by the FDA this time will help toripalimab enjoy certain policy support in the follow-up research and development, registration and commercialization of toripalimab in the United States , including but not limited to (1) taxation of clinical trial fees Credit; (2) New drug application fee waived; (3) 7-year market exclusivity after listing and not affected by patents .
-
Drugs for alcoholism may be next-generation anti-anxiety drugs
Time of Update: 2022-05-21
The study, published online March 7, 2022 in Frontiers in Pharmacology, describes how the research team used an elevated plus-maze (EPM) test -- used to screen for anxiolytics Drugs - to study the effects of DSF on mice .
-
【AACR 2022】A total of six preclinical progress of Ascentage Pharma at the 2022 American Association for Cancer Research Annual Meeting
Time of Update: 2022-05-21
/* Style Definitions */ span. prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a. prnews_a { color:blue; } li. prnews_li { font-size:8pt; font-family:"Arial"; color:black; } p. prnews
-
Large-scale COVID-19 study proves that whole-genome sequencing can accelerate therapeutic development
Time of Update: 2022-05-21
Last month, an international team of researchers published the results of a whole-genome sequencing that compared thousands of severely ill COVID-19 patients with controls, finding and repeating 23 independent variants that make individuals more likely to develop severe disease.
-
Siemens Healthineers and Junxin Medical have reached a strategic cooperation to jointly open a new chapter in one-stop cancer diagnosis and treatment
Time of Update: 2022-05-21
The two parties will integrate their respective resource advantages, work together to empower the development of non-public oncology medical care in the Greater Bay Area, and jointly create a new model of oncology diagnosis and treatment that is international, professional, personalized, and multi-disciplinary, and provides cancer patients with a life-cycle service.
-
Green Bamboo Bio uses Lonza GS Xceed(R) gene expression system to develop recombinant shingles vaccine and bispecific antibody
Time of Update: 2022-05-20
62em; font-family:"Arial"; color:black; margin:0in; } </> Green Bamboo and Lonza have reached a licensing agreement for GS Xceed® gene expression system and GS piggyBac® transposon technology Green Bamboo Bio uses Lonza's licensed technology to develop recombinant herpes zoster vaccine and therapeutic bispecific antibodies for relapsed or refractory B-cell non-Hodgkin's lymphoma and B-cell leukemia Basel, Switzerland and Beijing, China , April 19, 2022 /PRNewswire/ -- Beijing Green Bamboo Biotechnology Co.
-
Siemens Healthineers takes the lead in launching the "Expedition" 5G mobile emergency and critical care unit
Time of Update: 2022-05-20
To this end, Siemens Healthineers took the lead in launching the "Expedition" 5G mobile emergency and critical care unit for critically ill patients with chest pain and stroke during the epidemic to meet the needs of interventional treatment in different scenarios .
-
Yuyue Medical donated more than 3 million yuan of epidemic prevention and control materials to Shanghai Fangcai Hospital
Time of Update: 2022-05-20
prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a.
On April 18, the epidemic prevention and control materials donated by Yuyue Medical to Shanghai through the Shanghai Charity Foundation arrived at Shanghai Jiading Fangcang shelter hospital and Jinshan Fangcang shelter hospital .
-
SMART Medical colonoscope gets FDA clearance
Time of Update: 2022-05-20
prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a.
62em; font-family:"Arial"; color:black; margin:0in; } - FDA Approved G-EYE® for Use with Olympus ' 510 (k) Cleared PCF Colonoscope - RAANANA, Israel, April 20, 2022 /PRNewswire/ -- SMART Medical Systems Ltd.
-
BeiGene Announces Updated Results of RATIONALE-309, Phase 3 Clinical Trial of BeiGene(R) in First-Line Recurrent or Metastatic Nasopharyngeal Carcinoma at ASCO Plenary Session Series
Time of Update: 2022-05-20
5 monthsThe trial's secondary endpoint results were consistent with the interim analysisBEIJING, China, CAMBRIDGE, MA, USA and BASEL, Switzerland, April 19, 2022 /PRNewswire/ -- BeiGene (NASDAQ: BGNE; HK: 06160; S: 688235) is A global science-based biotechnology company focused on developing innovative, affordable medicines designed to improve outcomes and improve access to medicines for patients around the world .
-
The annual sales exceeded one million units, and the actual performance of Yuyue Medical continued the legend of oxygen production
Time of Update: 2022-05-20
As evidenced by the performance, relevant data from the China Medical Device Industry Association shows that the sales volume of Yuyue oxygen concentrators exceeded 1 million units last year, and the global market share exceeded 50.
-
The Hangzhou Medical Port of Yimao Medical Park is here!
Time of Update: 2022-05-18
At the meeting, we will gather in the cloud with everyone to discuss the industrialization of gene therapy drugs!hostHuating Pharmaceutical Analyst Caitong Securities Research InstituteA pharmaceutical analyst at Caitong Securities Research Institute, his main research direction is the field of innovative drugs and medical services .
-
Sartorius has a good start to the new fiscal year
Time of Update: 2022-05-18
/* Style Definitions */ span. prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a. prnews_a { color:blue; } li. prnews_li { font-size:8pt; font-family:"Arial"; color:black; } p. prnews
-
BPC guest lineup "star" force announced, promoting the acceleration of innovation of original research drugs
Time of Update: 2022-05-18
The BPC 2022 series of innovative drug conferences will be unveiled in Shanghai on July 14-15, 2022 . The conference is divided into 4 special sessions, starting from the two dimensions of innovativ
-
Eight years after the start of the competition, the competition was born, and the registration for the BioCon Awards has officially opened!
Time of Update: 2022-05-18
Created with ingenuity to help the development of the biopharmaceutical industry"BioCon Awards" is an authoritative biopharmaceutical award newly created by the BioCon China Expo 2022 Organizing Commi
-
"Measure" what you need, flexible and "ordered" The new SeqStudio Flex genetic analyzer is launched
Time of Update: 2022-05-18
”Renew CE, make everything possibleThe SeqStudio Flex Series Genetic Analyzers are based on proven Applied Biosystems technology, with improved optimized designs and technologies to make them efficient, flexible, easy to use, and intelligently connected .
-
PacBio Adds New Capabilities for Epigenomic Testing and Simplifies Sequencing
Time of Update: 2022-05-17
Using PacBio's single-molecule sequencing approach, researchers are able to detect modified bases in native DNA during standard HiFi sequencing, providing insights into the epigenome without additional time and cost .
-
Welcome to the Asian Games, protect your health!
Time of Update: 2022-05-17
62em; font-family:"Arial"; color:black; margin:0in; } </>Hangzhou , April 24, 2022 /PRNewswire/ -- In order to facilitate the construction of the healthy Asian Games and protect the occupational health rights of workers, from April 25 to May 1, Hangzhou will launch the 20th "Occupational Disease Prevention Law" publicity Weekly activities .
